Catalyst Wire Dossier Catalyst Wire Dossier

IL-YANG Quadrivalent Influenza Vaccine

· Il-Yang Pharm. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-YANG Quadrivalent Influenza Vaccine, covering 2020-05-11 to 2020-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents [Phase 3]

See pricing